Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.82 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | GALR3 | O60755 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 4/20 | 0.33 |
| ▸ | CA1 | P00915 | 4/20 | 0.33 |
| ▸ | CA2 | P00918 | 4/20 | 0.33 |
| ▸ | CA9 | Q16790 | 4/20 | 0.33 |
| ▸ | CA7 | P43166 | 3/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexane SCHEMBL6963396 | 1.00 | TSHR (0.82) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL21064874 | 0.91 | TSHR (1.00) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL19193 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL2107550 | 0.88 | — | — | |
| SCHEMBL4431010 | 0.88 | TSHR (0.93) | TSHRCHRM2CHRM4CHRM1TBXA2R | |
| SCHEMBL3495565 | 0.88 | — | — | |
| Methyl Alcohol SCHEMBL584909 | 0.88 | — | — | |
| SCHEMBL1278490 | 0.88 | — | — | |
| Ammonia Solution, Strong SCHEMBL5086843 | 0.88 | — | — | |
| Water SCHEMBL1289230 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0754975-B1 | Process of reducing trace levels of metal impurities from resist components | OLIN CORP (US) | 1999-09-01 | — | — | EP | claimed |
| US-5618655-A | Process of reducing trace levels of metal impurities from resist components | OLIN CORPORATION (US) | 1997-04-08 | — | — | US | claimed |
| EP-0754975-A2 | Process of reducing trace levels of metal impurities from resist components | OLIN CORPORATION (US) | 1997-01-22 | — | — | EP | claimed |
| JP-9034127-A | — | — | None | — | — | JP | disclosed |
| CN-119591813-A | Polyamide-s-triazine polymer, preparation method thereof and solid lubrication composite material | 季华实验室 | 2025-03-11 | — | — | CN | disclosed |
| US-20240239746-A1 | PREPARATION METHOD FOR PYRROLE AMIDE COMPOUND | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2024-07-18 | — | — | US | disclosed |
| EP-3727327-B1 | USE OF MAGNOLIA ABSOLUTE IN COSMETICS FOR DEPIGMENTING THE SKIN | ROBERTET SA (FR) | 2024-05-15 | — | — | EP | disclosed |
| CN-115246785-B | Process for preparing pyrrole amide compounds | 年衍药业(珠海)有限公司 | 2024-03-26 | — | — | CN | disclosed |
| EP-4332091-A1 | PREPARATION METHOD FOR PYRROLE AMIDE COMPOUND | Sunshine Lake Pharma Co., Ltd. (CN) | 2024-03-06 | — | — | EP | disclosed |
| US-20230301974-A1 | PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR | AMGEN INC. (US) | 2023-09-28 | — | — | US | disclosed |
| EP-4245299-A2 | Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate | Astrazeneca AB (SE) | 2023-09-20 | — | — | EP | disclosed |
| EP-0596067-A1 | ESSENTIAL OIL. | GIVAUDAN ROURE INT (CH) | 1994-05-11 | — | — | EP | disclosed |
| WO-1993023509-A1 | ESSENTIAL OIL | GIVAUDAN-ROURE (INTERNATIONAL) SA (CH) | 1993-11-25 | — | — | WO | disclosed |
| US-5134135-A | Antiandrogenic sulfonylsteroidooxazoles | STERLING DRUG INC. (US) | 1992-07-28 | — | — | US | disclosed |
| US-4816470-A | Heterocyclic compounds | GLAXO GROUP LIMITED | 1989-03-28 | — | — | US | disclosed |
| US-4795756-A | VASOCONSTRICTOR FOR MIGRAINE HEADACHE | GLAXO GROUP LIMITED (GB) | 1989-01-03 | — | — | US | disclosed |
| EP-0244085-A2 | 3-(2-Aminoethyl)indole derivatives | GLAXO GROUP LIMITED (GB) | 1987-11-04 | — | — | EP | disclosed |
| US-4025551-A | 3-Amino-N-substituted succinamic acids | G. D. SEARLE & CO. (US) | 1977-05-24 | — | — | US | disclosed |
| US-4011260-A | 3-AMINO-N-SUBSTITUTED SUCCINAMIC ACIDS AND INTERMEDIATES THERETO | G. D. SEARLE & CO. (US) | 1977-03-08 | — | — | US | disclosed |
| JP-H00934127-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239746-A1 | PREPARATION METHOD FOR PYRROLE AMIDE COMPOUND | HPGDS, HRH4, FAAH | TSHR 794/4885CHRM2 1763/4885CHRM4 1644/4885 |
| US-20230301974-A1 | PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR | MDM2, TP53, TP53BP1 | TSHR 3716/4885CHRM2 3092/4885CHRM4 3348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.